Reconstituted Complex

An interaction is detected between purified proteins in vitro.

Publication

Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33.

Azoitei N, Hoffmann CM, Ellegast JM, Ball CR, Obermayer K, Goessele U, Koch B, Faber K, Genze F, Schrader M, Kestler HA, Doehner H, Chiosis G, Glimm H, Froehling S, Scholl C

Previous efforts to develop drugs that directly inhibit the activity of mutant KRAS, the most commonly mutated human oncogene, have not been successful. Cancer cells driven by mutant KRAS require expression of the serine/threonine kinase STK33 for their viability and proliferation, identifying STK33 as a context-dependent therapeutic target. However, specific strategies for interfering with the critical functions of STK33 are ... [more]

J. Exp. Med. Apr. 09, 2012; 209(4);697-711 [Pubmed: 22451720]

Throughput

  • Low Throughput

Related interactions

InteractionExperimental Evidence CodeDatasetThroughputScoreCurated ByNotes
STK33 USP15
Affinity Capture-MS
Affinity Capture-MS

An interaction is inferred when a bait protein is affinity captured from cell extracts by either polyclonal antibody or epitope tag and the associated interaction partner is identified by mass spectrometric methods.

High-BioGRID
724390

Curated By

  • BioGRID